Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-25-000596
Filing Date
2025-01-21
Accepted
2025-01-21 16:00:07
Documents
2
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K fsd_6k.htm 6-K 13903
2 FORM 7 - MONTHLY PROGRESS REPORT fsd_ex991.htm EX-99.1 64490
  Complete submission text file 0001654954-25-000596.txt   79601
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 25542456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)